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Microbial polyhydroxyalkanoates (PHA) have been produced as bioplastics for various purposes. Under
the support of China National Basic Research 973 Project, we developed synthetic biology methods to
diversify the PHA structures into homo-, random, block polymers with improved properties to better
meet various application requirements. At the same time, various pathways were assembled to produce
various PHA from glucose as a simple carbon source. At the end, Halomonas bacteria were reconstructed
to produce PHA in changing morphology for low cost production under unsterile and continuous con-
ditions. The synthetic biology will advance the PHA into a bio- and material industry.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Polyhydroxyalkanoates (PHA), polylactic acid (PLA), poly(-
butylene succinate) (PBS), polyethylene (PE), poly(trimethylene
terephthalate) (PTT), polypropylene (PPP), polyethyleneTsinghua University, Beijing
Q. Chen).
ng by Elsevier B.V. on behalf of KeAterephthalate (PET) and poly(propylene carbonate) (PPC) are
biodegradable or biobased polymers with at least one monomers
produced by microbial conversions or microbial industrial
biotechnology [1]. The weaknesses of microbial or enzymatic pro-
cesses compared with the chemical processing make industrial
biotech products less competitive with the chemical ones. How-
ever, taking advantages of the molecular biology and synthetic
biologymethods as well as changing process patterns, bioprocesses
could be developed as competitive as chemical ones, thesei Communications Co. This is an open access article under the CC BY-NC-ND license
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processes et al. [2] This review aims to report progresses made by
the China National Basic Science Research Project 973 during
2012e2016 on synthetic biology of PHA.
Many bacteria have been found to produce various poly-
hydroxyalkanoates (PHA) biopolyesters. Inmany cases, it is not easy
to control the structures of PHA including homopolymers, random
copolymers and block copolymers as well as ratios of monomers in
the copolymers. However, the weakening of beta-oxidation cycle in
Pseudomonas putida and Pseudomonas entomophila led to control-
lable synthesis of all kinds of PHA structures including monomer
ratios in random and/or block copolymers when fatty acids are
used as PHA precursors. Introduction of functional groups into PHA
polymer chains in predeﬁned proportions has become a reality
provided fatty acids containing the functional groups are taken up
by the bacteria for PHA synthesis. This allows the formation of
functional PHA for further grafting (Fig. 1). The PHA diversity is
further widened by the endless possibility of controllable homo-
polymerization, random copolymerization, block copolymerization
and grafting on functional PHA site chains(Fig. 1) [3].
PHA diversity is generated by engineering the three basic syn-
thesis pathways including the acetoacetyl-CoA pathway (pathway
I), in situ fatty acid synthesis (pathway II), and/or beta-oxidation
cycles (pathway III), as well as PHA synthase speciﬁcity and pro-
cess control. It is now possible to tailor the PHA structures via
genome editing or process engineering. The increasing PHA di-
versity and maturing PHA production technology should lead to
more focused research into their low-cost and/or high-value ap-
plications [4] (see Fig. 2).
Similarly to the genome, transcriptome, and proteome, the PHA
spectrum exhibits diverse and dynamic modiﬁcations e the term
'PHAome' has been created to reﬂect not only the diversity of
monomers, homopolymers, random and block copolymers, func-
tional and graft polymers, molecular weights, and combinations of
the above, but also the ranges of PHAs with various molecularFig. 1. Introduction of functional groups into PHA polymer chains in predeﬁned proportions
by the bacteria for PHA synthesis. The PHA diversity is further widened by the endless po
merization and grafting on functional PHA site chains [3].weights and monomer ratios that are present at a particular time
point in a bacterial cell. It has become very important to understand
the PHAome and ensuring an ample supply of PHAs to promote the
discovery of new properties and applications of this family of
advanced materials [5].2. The development of new technology for pathway cloning
and assembly
PHA synthesis involves a lot of pathways. However, construction
of large gene clusters containing DNA fragments is still a difﬁcult
and expensive task. To tackle this problem for complicate PHA
synthesis pathway assembly, we developed a gene cluster extrac-
tion method based on in vitro single-strand overlapping annealing
(SSOA). It starts with digesting the target gene cluster in an existing
genome, followed by recovering digested chromosome fragments.
Subsequently, the single-strand DNA overhangs formed from the
digestion process would be speciﬁcally annealed and covalently
joined together with a circular and a linear vector, respectively. The
method could clone a 18 kb DNA fragment encoding NADH: ubi-
quinone oxidoreductase. Combined with genetic information from
KEGG and the KEIO strain collection, this method will be useful to
clone any speciﬁc region of an E. coli genome at sizes less than
similar to 28 kb. The method provides a cost-effective way for
genome assembly, alternative to expensive chemically synthesized
gene clusters [6].
Anaerobic metabolic pathways dedicated to co-production of
hydrogen and PHB were established in E. coli due to the advantages
of directing ﬂuxes away from toxic compounds such as formate and
acetate to useful products. E. coli over-expressing very large hy-
drogenase 3 cloned using the above SSOA method and/or acetyl-
CoA synthase showed improved poly-3-hydroxybutyrate (PHB)
and hydrogen production when grownwith or without acetate as a
carbon source [7].
A method was developed to generate single-stranded DNAhas become a reality provided fatty acids containing the functional groups are taken up
ssibility of controllable homopolymerization, random copolymerization, block copoly-
Fig. 2. PHA diversity is generated by engineering the three basic synthesis pathways including the acetoacetyl-CoA pathway (pathway I), in situ fatty acid synthesis (pathway II),
and/or beta-oxidation cycles (pathway III), as well as PHA synthase speciﬁcity [4,5].
G.-Q. Chen et al. / Synthetic and Systems Biotechnology 1 (2016) 236e242238overlaps based on Nicking Endonucleases (NEases) for DNA
ligation-independent cloning LIC, the method was termed NE-LIC.
This NE-LIC allows generating 3'-end or 5'-end ss DNA overlaps of
various lengths for fragments assembly. The mechanism can be
applied to many other LIC strategies. Finally, the NE-LIC was suc-
cessfully applied to assemble a pathway of six gene fragments
responsible for synthesizing microbial PHB [8].
It is very important to assemblemultiple DNA (genes) fragments
into a large circular DNA structure in one step in synthetic biology.
We successfully used linear plasmid and Cyclization After Trans-
formation (CAT) strategy to conduct DNA linear assembly combined
with CAT method to demonstrate an increased overall construction
efﬁciency for assembling multiple DNA (genes) fragments. It has
been used in construction of a VB12 metabolic pathway consisting
of multiple genes [9].
Bacterial hemoglobin promoters Pvgb were cascaded assembled
for enhanced expression under micro-aerobic growth. The highest
PHB production was obtained when a promoter containing eight
cascaded Pvgb repeats P8vgb was used. This study revealed that vgb
promoter containing cascaded repeats P8vgb was useful for product
formation under low aeration intensity [10].
3. Designing new pathways for new PHA synthesis by E. coli
or Pseudomonas
Block PHA were reported to be resistant against polymer aging
that negatively affects polymer properties. Diblock copolymers
PHB-b-PHHx consisting of poly-3-hydroxybutyrate (PHB) block
covalently bonded with poly-3-hydroxyhexanoate (PHHx) block
were therefore produced by a recombinant Pseudomonas putida
KT2442 with its beta-oxidation cycle deleted to its maximum. It is
possible to produce PHA block copolymers of various kinds using
the recombinant Pseudomonas putida KT2442 with its beta-
oxidation cycle deleted to its maximum [11].
Poly(4-hydroxybutyrate) (P4HB) is a highly elastic polymer,
whereas poly(3-hydroxypropionate) (P3HP) is a polymer with
enormous tensile strength. A recombinant Escherichia coli that
produces homopolymers of P3HP and P4HBwas constructed for the
synthesis of the block copolymers [12]. When the strain was grown
in the presence of 1,4-butanediol (BDO) as a 4HB precursor, P4HB
block was formed. Sequential supplementation of 1,3-propanediol
(PDO) as a 3HP precursor allowed formation of a block copolymerof p3HP-b-P4HB. Block copolymerization of P3HP and P4HB adds a
new vision on PHA polymerization by generation of new polymers
with superior properties [13].
At the same time, copolyesters of 3-hydroxypropionate (3HP)
and 4-hydroxybutyrate (4HB), abbreviated as P(3HP-co-4HB), was
synthesized by the same Escherichia coli harboring a synthetic
pathway consisting of ﬁve heterologous genes including orTZ
encoding 4-hydroxybutyrate-coenzyme A transferase from Clos-
tridium kluyveri, pcs' encoding the ACS domain of tri-functional
propionyl-CoA ligase (PCS) from Chloroﬂexus aurantiacus, dhaT
and aldD encoding dehydratase and aldehyde dehydrogenase from
Pseudomonas putida KT2442, and phaC1 encoding PHA synthase
from Ralstonia eutropha [14]. A pathway was constructed in
Escherichia coli for the production of P(3HB-co-4HB) from glucose.
Native gene sad encoding E. coli succinate semi-aldehyde dehy-
drogenase was expressed under the control of CRISPRi, using ﬁve
specially designed single guide RNAs (sgRNAs) for regulating car-
bon ﬂux to 4-hydroxybutyrate (4HB) biosynthesis. The system
allowed formation of P(3HB-co-4HB) consisting of 1e9mol% 4HB. It
was found that CRISPRi was a feasible method to simultaneously
manipulate several genes in E. coli [15].
Meng et al. in this lab further constructed a pathway in E. coli for
production of poly(3-hydroxypropionate) and p(3-
hydroxybutyrate-co-3-hydroxypropionate) from glucose, demon-
strating the feasibility of using various pathways in E. coli for pro-
duction of diverse PHA [16].
The beta-oxidation weakened Pseudomonas putida was estab-
lished as a platform for the production of polyhydroxyalkanoates
(PHA) with adjustable monomer compositions and micro-
structures. Its produced a novel diblock copolymer P3HHx-b-
P(3HD-co-3HDD) consisting of 49 mol% P3HHx and 51 mol%
P(3HD-co-3HDD) [35.25 mol% 3HDD (3-hydroxydodecanoate)]
[17].
This lab succeeded to synthesize controllable composition of
poly(3-hydroxyalkanoate) (PHA) consisting of 3-
hydroxydodecanoate (3HDD) and phenyl group on the side-chain
when chromosome of Pseudomonas entomophila was edited to
weaken its b-oxidation. Cultured in the presence of 5-phenylvaleric
acid (PhV), the edited Pseudomonas entomophila produced only
homopolymer poly(3-hydroxy-5-phenylvalerate) or P(3HPhV).
While copolyesters P(3HPhV-co-3HDD) of 3-hydroxy-5-
phenylvalerate (3HPhV) and 3-hydroxydodecanoate (3HDD) were
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valeric acid and dodecanoic acid. It was possible to tailor-made
novel functional PHA using the chromosome edited Pseudomonas
entomophila [18,19].
A semi-rational approach for high-efﬁcient PHB pathway opti-
mization in E. coli based on PHB synthesis phbCAB operon cloned
from native producer Ralstonia entropha (R. entropha) was devel-
oped (Fig. 3). Rational designed Ribosomal Binding Sites (RBS) li-
braries with deﬁned strengths for each of the three genes, were
constructed based on high or low copy number plasmids in a one-
pot reaction by an Oligo-Linker Mediated Assembly (OLMA)
method. Applying this approach, strains accumulating 0%e92% PHB
contents in Cell Dry Weight (CDW) were achieved. The semi-
rational approach combining library design, construction, and
proper screening is an efﬁcient way for PHB and other multi-
enzyme pathways optimization [20].
PHBHHx copolymer poly(3-hydroxybutyrate-co-3-
hydroxyhexanoate) production suffers from high cost due to
expensive C12 fatty acid. Wang et al. [21] designed metabolic
pathways to synthesize P(HB-co-HHx) directly from glucose using
recombinant Escherichia coli. By combining the BktB-dependent
condensation pathway with the inverted beta-oxidation cycle
pathway, they were able to synthesize a PHBHHx with a 10 mol%
HHx fraction in the E. coli.
By engineering the reversed fatty acid beta-oxidation cycle,
Zhuang et al. [22] were able to synthesize medium-chain-length
(mcl) PHA in Escherichia coli directly from glucose. Furthermore,
when a low-substrate-speciﬁcity PHA synthase from Pseudomonas
stutzeri 1317 was employed, recombinant E. coli synthesized 12 wt%Fig. 3. Scheme for PHB pathway optimization. Applying proper rational design ap-
proaches like RBS library design, the capacity of possible variations in a library can be
reduced from random combinations to a smaller number of combinations (103), then
the rational designed library was successfully constructed through one-step OLMA
method. On-plate visual selection was involved to identify pathways accumulating
PHB and reduce the library capacity to 102. High throughput screening via FACS to
screen PHB producers can further reduce the interested pathways for further detailed
analysis to about 101. Detailed analysis can be carried out according to different re-
quirements, the desired optimized pathway can thus be selected from the library [20].of cell dry weight short-chain-length (scl) and medium-chain-
length (mcl) PHA or scl-mcl PHA copolymers, of which 21mol%
was 3-hydroxybutyrate and 79mol% was medium-chain-length
monomers. The reversed fatty acid beta-oxidation cycle offered
an efﬁcient metabolic pathway for mcl-PHA biosynthesis in E. coli
and can be further optimized.
Polylactide (PLA) is another representative of bio-based biode-
gradable polyester and has been used in areas of biomedical im-
plants, food packaging and drug delivery because of its lower price.
However, a large scale application of PLA has been hampered by a
disadvantage of poor thermal and mechanical properties. There-
fore, copolymerization of LA with other hydroxyalkanoate (HA)
monomers is a better choice to improve the physical properties of
PLA or PHA. Recently, several polyhydroxyalkanoate (PHA) syn-
thases were engineered to utilize lactyl-CoA (LA-CoA) and 3-
hydroxybutyryl-CoA (3HB-CoA) as substrates [23,24]. Taguchi re-
ported the one-step biosynthesis of the LA-incorporated PHA
copolyester, P(6 mol% LA-co-94 mol% 3HB), with a number-average
molecular weight of 1.9  105. However, the property of copolymer
does not have too much change because mechanical properties of
PHB are similar to PLA [23]. Therefore, Shozui et al. introduced
other monomers such as 3-hydroxyvalerates (3HV), 3-
hydroxyhexanoate (3HHx) into the LA copolymers for better and
more diverse properties [25e27]. Li et al. constructed an E. coli
strain to produce a novel glycolate-containing biopolymers poly(-
glycolate-co-lactate-co-3-hydroxybutyrate) from glucose. The re-
combinant E. coliwas able to accumulate the novel terpolymer with
a titer of 3.90 g/L in shake ﬂask cultures [28]. Assessment of thermal
and mechanical properties demonstrated that the resulted
terpolymer possessed decreased crystallinity and improved
toughness, in comparison to poly(3-hydroxybutyrate)
homopolymer.
4. Bacterial morphology engineering
Many bacteria can accumulate inclusion bodies such as sulfur,
polyphosphate, glycogen, proteins or PHA. A larger intracellular
space is needed for more inclusion body storages. Various ap-
proaches were taken to increase the bacterial cell sizes including
deletion on actin-like protein gene mreB, weak expression of mreB
in mreB deleted mutant, and weak expression of mreB in mreB
deleted mutant under inducible expression of division ring FtsZ
inhibiting protein SulA, all resulted in increasing bacterial sizes and
PHB granules accumulation (Fig. 4). It was found that over 100%
PHB accumulation increase was observed in E. coli overexpressing
of mreB in mreB deleted mutant under inducible expression of FtsZ
inhibiting protein SulA [29e31].
5. Halomonas based biotechnology and synthetic biology
Disadvantages of bioprocessing are obvious: most fermentation
(bioprocessing) processes are discontinuous ones lasting one to
several weeks. Bioprocessing consumes a lot of precious fresh
water, the sterilization and aeration processes also demand a lot of
energy. In addition, ﬁnal products in fermentation broths are
generally very low, ranging from mg to 200 g/L. The lower yield
leads to a high downstream puriﬁcation cost. In contrast, chemical
industry can reach at least 500 g/L at the end of the process. Most
seriously, the substrate to product conversion efﬁciency is very low
in fermentation, in PHA industry, the most common substrate to
PHA conversion stands around 1/3 or 33% (g/g), while the chemical
synthesis of plastics such as PE, PET or PS et al. can be as high as
over 90% or even close to 100% (Table 1) [32]. We must learn from
the advantages of chemical industries while maintaining the ad-
vantages of bioprocessing. New technology should be developed to
Fig. 4. Electron microscopy studies on morphology and PHB production by E. coli JM109SG (DmreB) overexpressing mreB [30].
Table 1
Comparisons between bio- and chemical processing [32].
Comparison parameter Biotechnology Chemical technology
Raw materials Sustainable agriculture resources including CO2 Petroleum
Reaction conditions Ambient temperature and atmosphere pressure, aqueous medium Mostly under high temperature, high pressure and organic
solvents
Process Mostly discontinuous batch processes Mostly continuous processes
Process duration From inoculation to fermentations to downstream take one to two
weeks
Mostly completed within days
Energy consumption High due to sterilization and continuous aeration Depending on products
Water consumption Heavy water consumption Less water consumption
Final product conc. Mostly low, from mg to 200 g/L Mostly over 500 g/L
Cost of product recovery Very high Low
Substrate to product conversion
efﬁciency
Low Mostly very high
Risk Low level High due to ﬂammable, explosive, toxic gas or product
leakages
Waste water Mostly non-toxic and easily treated Mostly toxic, acidic or alkali, difﬁcult to treat
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nology we developed supported by the National Basic Research 973
project represents the Advanced Bioprocessing to learn from
Chemical Industries [33,34].
Halophilic bacteria offer such possibilities as they grow in me-
dium to high salt concentrations under high pH in a wide tem-
perature window, such growth conditions.
can effectively prevent contamination by other microorganisms
[33]. In this lab halophilic bacteria were grown in unsterile and
continuous processes in seawater like medium for at least one
month without any microbial contamination [35], technology has
also been developed for genetic manipulation of halophilic bacte-
ria, allowing the synthetic biology construction of abovementioned
super PHA production strains [36] for production of PHBV co-
polymers consisting of 3-hydroxybutyrate (HB) and 3-
hydroxyvalerate (HV) with high substrate to PHA conversion efﬁ-
ciency [37]. In addition, New Haloarchaea has also been found to
produce PHBV [38].
It is commonly known that chromosomal expression is more
stable yet weaker than plasmid one is. To overcome this challenge, anovel chromosomal expression method was developed for halo-
phile Halomonas TD01 and its derivatives based on a strongly
expressed porin gene as a site for external gene integration. The
gene of interest was inserted downstream the porin gene, forming
an artiﬁcial operon porin-inserted gene. This chromosome expres-
sion system was proven functional by chromosomal expression of
heterologous PHB synthase gene to completely restore the PHB
accumulation in endogenous phaC knockout Halomonas TD01. The
integrated heterologous PHB synthase gene was expressed at the
highest level when inserted at the locus of porin compared with
insertions in other chromosome locations. An inducible system
allowed on-off switch of gene expression in Halomonas TD strains
was also developed based on porin. The stable and strong chro-
mosomal expression method in Halomonas TD spp was established
[39].
Systems and synthetic biology approaches have been studied to
design and construction a PHA super production strain able to grow
fast to high cell density (>200 g/L) utilizing low cost substrates
including cellulose, starch or even kitchenwastes under a very high
carbon source to PHA conversion efﬁciency of at least 50% (g/g)
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induced >90% PHA accumulation in cell dry weights. After
completing the PHA production, the very large cells will be induced
for ﬂocculation precipitation followed by induced cell lysis to
release large PHA granules. Based on these design, the cost of PHA
will be reduced to 50% of the original.
The above super PHA production strain (Fig. 5) will be con-
structed to allow precisely control their PHA structures to form
homopolymers, random- and block copolymers as well as func-
tional polymers with precise monomer structures and ratios for
consistent properties. High value added applications based on
unique PHA polymer properties and chiral hydroxyalkanoic acids
will be developed for the high end markets.6. PHA production from waste material
Waste materials or waste water can be used to produce PHA,
which provides a cost reduction. Pittmann and Steinmetz reported
the production of polyhydroxyalkanoates (PHAs) as a side stream
process on a municipal waste water treatment plant (WWTP) at
different operation conditions. It was demonstrated a strong in-
ﬂuence of the operating conditions on the PHA production. Lower
substrate concentration, 20 C, neutral pH-value and a 24 h cycle
time are preferable for high PHA production up to 28.4% of cell dry
weight (CDW) [40]. PHA composition was inﬂuenced by cycle time
only and a stable PHA composition was reached.
Yue et al. isolated a halophile Halomonas campaniensis strain
LS21 which could use kitchen wastes like mixed substrates as nu-
trients for production of bioplastic PHB. The recombinant
H. campaniensis LS21 containing a PHB synthesis genes phbCABwas
grown in artiﬁcial seawater containing mixed substrates similar to
kitchen wastes (soluble and insoluble cellulose, proteins, fats, fatty
acids and starch) for 65 days without interruption. In the presence
of 27 g/L NaCl under a pH around 10 at 37 C, the recombinant
produced approximately 70% PHB during the 65 days fermentation
process. This study demonstrates the advantages of this strain in
terms of low cost substrates (kitchen wastes like mixed substrates)
[41]. The strain is currently being used as a chassis for many syn-
thetic biology study.7. Future prospects
The large scale application of PHA as a low biodegradable plastic
has been hampered by its higher production cost. The recent ad-
vances on systems and synthetic biology provides feasible tech-
nologies for developing a super microorganism capable of
producing diverse PHAwith a low cost. Among various host strains,
halophilic bacteria are becoming more and more attractive due to
their unique properties including strong adaptation to high osmotic
pressure and high pH thus agaist contaminations. All of these
unique properties make halophiles as candidates of a super chassis
for a lot of engineerings. With the application of syntheticFig. 5. Desirable properties for a PHA industrial production strain [32].technologies, the halophiles should be constructed to have the
capacity of growing fast to high cell density and produce PHA with
diverse properties, a high conversion efﬁciency from carbon source
to PHA. Also, easy downstream processing technologies should be
developed for halophiles so that the product PHA can be compet-
itive in cost with petroleum plastics.
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